Avalo Therapeutics (AVTX) Gross Margin Growth (3y) (2020 - 2024)
Powered by 
Analysis
Avalo Therapeutics (AVTX) Gross Margin Growth (3y) (2020 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 569.00 |
| 10 | Avalo Therapeutics | 835.85 Mn | 835.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -21,949.00 |
| Dec 31, 2023 | 4,398.00 |
| Sep 30, 2023 | -9,773.00 |
| Jun 30, 2023 | -10,428.00 |
| Mar 31, 2023 | -11,360.00 |
| Dec 31, 2022 | -52,969.00 |
| Sep 30, 2022 | 248.00 |
| Jun 30, 2022 | -4,479.00 |
| Mar 31, 2022 | -3,244.00 |
| Dec 31, 2021 | -15,976.00 |
| Sep 30, 2021 | 909.00 |
| Jun 30, 2021 | 2,726.00 |
| Mar 31, 2021 | 299.00 |
| Dec 31, 2020 | 2,799.00 |
| Sep 30, 2020 | -693.00 |
| Jun 30, 2020 | -583.00 |
| Mar 31, 2020 | -240.00 |